1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, YH; Yang, MF | 1 |
| Arbeit, JM; Chang, AJ; Lapi, SE; Lu, ZH; Sohn, R | 1 |
2 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Cancer of Kidney
| Article | Year |
|---|---|
Increased 18F-ALF-NOTA-FAPI and 18F-FDG Uptake in Renal Angiomyolipoma.
Topics: Angiomyolipoma; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET.
Topics: Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Everolimus; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Kidney Neoplasms; Mice; Neovascularization, Pathologic; Phosphorylation; Positron-Emission Tomography; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |